Operating Lease, Right-of-Use Asset of Senti Biosciences, Inc. from 31 Dec 2021 to 30 Sep 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's right to use underlying asset under operating lease.
Summary: Senti Biosciences, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2021 to 30 Sep 2025.
Senti Biosciences, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $12,262,000, a 15% decline year-over-year.
Source SEC data: View on sec.gov

Operating Lease, Right-of-Use Asset, Quarterly (USD)

Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Senti Biosciences, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$12,262,000	-$2,208,000	-15%	30 Sep 2025	10-Q	13 Nov 2025	2025	Q3
Q2 2025	$12,845,000	-$2,456,000	-16%	30 Jun 2025	10-Q	07 Aug 2025	2025	Q2
Q1 2025	$13,407,000	-$2,390,000	-15%	31 Mar 2025	10-Q	06 May 2025	2025	Q1
Q4 2024	$13,948,000	-$2,326,000	-14%	31 Dec 2024	10-Q	13 Nov 2025	2025	Q3
Q3 2024	$14,470,000	-$2,548,000	-15%	30 Sep 2024	10-Q	14 Nov 2024	2024	Q3
Q2 2024	$15,301,000	-$2,168,000	-12%	30 Jun 2024	10-Q	13 Aug 2024	2024	Q2
Q1 2024	$15,797,000	-$2,108,000	-12%	31 Mar 2024	10-Q	09 May 2024	2024	Q1
Q4 2023	$16,274,000	-$2,144,000	-12%	31 Dec 2023	10-K	20 Mar 2025	2024	FY
Q3 2023	$17,018,000	-$1,865,000	-9.9%	30 Sep 2023	10-Q	14 Nov 2023	2023	Q3
Q2 2023	$17,469,000	-$2,005,000	-10%	30 Jun 2023	10-Q	11 Aug 2023	2023	Q2
Q1 2023	$17,905,000			31 Mar 2023	10-Q	09 May 2023	2023	Q1
Q4 2022	$18,418,000	-$2,290,000	-11%	31 Dec 2022	10-K	21 Mar 2024	2023	FY
Q3 2022	$18,883,000			30 Sep 2022	10-Q	10 Nov 2022	2022	Q3
Q2 2022	$19,474,000			30 Jun 2022	10-Q	15 Aug 2022	2022	Q2
Q4 2021	$20,708,000			31 Dec 2021	10-K	22 Mar 2023	2022	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.